Division of Hematology/Oncology

Faculty

faculty photo

Angela M DeMichele, MD MSCE

Alan and Jill Miller Associate Professor in Breast Cancer Excellence
Senior Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
Co-Leader, Breast Cancer Program, Abramson Cancer Center, University of Pennsylvania
Program Leader, Doris Duke Clinical Research Fellowship Program, University of Pennsylvania
Department: Medicine

Contact information
Perelman Center for Advanced Medicine
3 West Pavilion
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-349-5730
Fax: 215-615-3349
Graduate Group Affiliations
Education:
B.A. (Biochemistry)
Brown University, 1988.
M.D. (Medicine)
Washington University School of Medicine, 1991.
M.S.C.E. (Clinical Epidemiology)
University of Pennsylvania, School of Medicine, 2001.
Post-Graduate Training
Intern in Obstetrics and Gynecology, Hospital of the University of Pennsylvania, 1991-1992.
Resident in Medicine, Hospital of the University of Pennsylvania, 1992-1994.
Visiting Clinical Fellow, Istituto di Ematologia Seràgnoli, Institute of Hematology, Università degli Studi di Bologna, 1994-1995.
Fellowship, Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, 1995-1998.
Certifications
National Board of Medical Examiners, 1992.
American Board of Internal Medicine (Medicine), 1995.
American Board of Internal Medicine (Onc Subspecialty), 1998.
American College of Epidemiology , 2002.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

breast cancer, biomarkers, clinical trials, pharmacogenetics, cytokines, host immunogenetics, cancer survivorship, molecular epidemiology

Description of Clinical Expertise

breast cancer, neoadjuvant therapy, menopausal symptoms related to cancer, cancer survivorship

Selected Publications

Palmer SC, Jacobs LA, DeMichele A, Risendal B, Jones AF, Stricker CT: Metrics to evaluate treatment summaries and survivorship care plans: A scorecard. Supportive Care in Cancer 22(6): 1475-83, June 2014.

Bauml J, Xie S, Farrar J, Bruner D, Stricker C, Bowman M, DeMichele A, Mao J: Expectancy in real and sham acupuncture: does believing make it so? Journal of Alternative and Complementary Medicine 20(5), May 2014.

Clark AS, Chen J, Kapoor S, Friedman C, Mies C, Esserman L, DeMichele A, I-SPY1 Investigators: Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY Trial (CALGB 150007). Cancer Medicine epub ahead of print, April 2014.

LeBlanc M, Stineman M, DeMichele A, Stricker C, Mao JJ: Validation of QuickDASH outcome measure in breast cancer survivors for upper extremity disability. Archives of Physical Medicine and Rehabilitation 95(3): 493-8, March 2014.

Mao JJ, Xie SX, Farrar JT, Stricker CT, Bowman MA, Bruner D, DeMichele A: A randomized trial of electro-accupuncture for arthralgia related to aromatase inhibitor use. European Journal of Cancer 50(2): 267-76, January 2014.

Chim K, Xie SX, Stricker CT, Li QS, Gross R, Farrar JT, DeMichele A, Mao JJ: Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors. BMC Cancer 13: 401, September 2013.

Speck RM, Sammel MD, Farrar JT, Hennessy S, Mao JJ, Stineman MG, DeMichele A: Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in non-metastatic breast cancer. Journal of Oncology Practice 9(5): 234-40, September 2013.

Alvarez JV, Pan TC, Ruth J, Feng Y, Zhou A, Pant D, Grimley JS, Wandless TJ, DeMichele A; I-SPY 1 TRIAL Investigators, Chodosh LA.: Par-4 downregulation promotes breast cancer recurrence by preventing multinucleation following targeted therapy. Cancer Cell 24(1), July 2013.

Demichele A, Berry DA, Zujewski J, Hunsberger S, Rubinstein L, Tomaszewski JE, Kelloff G, Perlmutter J, Buxton M, Lyandres J, Albain KS, Benz C, Jo Chien A, Haluska P, Leyland-Jones B, Liu MC, Munster P, Olopade O, Park JW, Parker BA, Pusztai L, Tripathy D, Rugo H, Yee D, Esserman L.: Developing Safety Criteria for Introducing New Agents into Neoadjuvant Trials. Clinical Cancer Research 19(11): 2817-2823, June 2013.

Gabriel CA, Mitra N, DeMichele A, Rebbeck T: Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women. Breast Cancer Research and Treatment 139(3): 833-43, June 2013.

back to top
Last updated: 09/12/2014
The Trustees of the University of Pennsylvania
 

Clinical Briefings Blog Spot

Penn MD Forum title with Penn Medicine Shield and Twitter